| Acronym | CReST2 |
|---|---|
| Number | ISRCTN54834267 |
| Protocol Link | https://www.journalslibrary.nihr.ac.uk/programmes/hta/142802/#/documentation |
| Public Trial Registry Link | http://www.isrctn.com/ISRCTN54834267 |
| Status | Open/recruiting |
| Category | Colorectal Cancer - All |
| Treatment Course | Adjuvant, palliative or post-op |
| Stenting now has an accepted role in the palliative care of people with colorectal cancer. However, there is little evidence of which type of stent is best to use - covered or uncovered. To provide robust evidence, CReST2 is a blinded, randomised controlled trial. 350 patients will be randomised to receive either a covered or uncovered stent to relieve bowel obstruction due to colorectal cancer. |
|
Professor James Hill Consultant General and Colorectal Surgeon |
| Profile Link |
|
Central Manchester University Hospitals NHS Foundation Trust: Manchester Royal Infirmary Oxford Road Manchester M13 9WL United Kingdom |
| Website |